LINC02484: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC02484

NCBI ID: G105374394

Other Name(s): long intergenic non-protein coding RNA 2484 | Uncharacterized LOC105374394, transcript variant X1 | LOC105374394 variant X1

LINC02484: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC02484 is a long non-coding RNA (lncRNA) that has been identified in various cellular processes. It is expressed in various tissues and cells throughout the body and has been associated with various diseases, including cancer. The discovery of LINC02484 as a potential drug target or biomarker has significant implications for the development of new treatments for these diseases.

Drug Target

LINC02484 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to promote the growth of cancer cells and has been associated with the development of various types of cancer, including lung, breast, and ovarian cancer.

In addition to its role in cancer, LINC02484 has also been shown to contribute to the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. It has been shown to participate in the regulation of neurotransmitter signaling and has been associated with the misregulation of various neurotransmitter systems, including dopamine, serotonin, and GABA.

Biomarker

LINC02484 has also been shown to serve as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and mental health conditions. Its expression has been associated with the development of various diseases and has been shown to be downregulated in various diseases, including cancer.

The potential use of LINC02484 as a biomarker has significant implications for the early detection and diagnosis of diseases. It has the potential to serve as a diagnostic marker for various diseases and can also be used as a target for new therapies.

Pathway

LINC02484 is involved in various signaling pathways, including the NF-kappa pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. It has been shown to regulate the activity of various transcription factors, including NF-kappa1, PDGF-1, and NF-kappa-B1.

It has also been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and invasion. It has been shown to contribute to the development of various diseases, including cancer, neurodegenerative diseases, and mental health conditions.

Conclusion

LINC02484 is a long non-coding RNA that has been shown to play a role in various cellular processes and has been associated with various diseases. Its potential as a drug target or biomarker has significant implications for the development of new treatments for these diseases. Further research is needed to fully understand the role of LINC02484 in various cellular processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2484

More Common Targets